BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7682874)

  • 1. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
    Solcia E; Rindi G; Silini E; Villani L
    Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach.
    Håkanson R; Böttcher G; Sundler F; Vallgren S
    Digestion; 1986; 35 Suppl 1():23-41. PubMed ID: 3539678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
    Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
    Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hypergastrinaemia dangerous to man?
    Creutzfeldt W; Lamberts R
    Scand J Gastroenterol Suppl; 1991; 180():179-91. PubMed ID: 1675024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
    Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
    Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion.
    Havu N
    Digestion; 1986; 35 Suppl 1():42-55. PubMed ID: 3792671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.
    Mattsson H; Havu N; Bräutigam J; Carlsson K; Lundell L; Carlsson E
    Gastroenterology; 1991 Feb; 100(2):311-9. PubMed ID: 1985029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of gastric acid secretion - clinical perspectives.
    Waldum HL; Hauso Ø; Fossmark R
    Acta Physiol (Oxf); 2014 Feb; 210(2):239-56. PubMed ID: 24279703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin and the trophic control of gastric mucosa.
    Håkanson R; Oscarson J; Sundler F
    Scand J Gastroenterol Suppl; 1986; 118():18-30. PubMed ID: 3460169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat stomach enterochromaffin-like cells are not stimulated by pylorus ligation. A biochemical and ultrastructural study.
    Zhao CM; Chen D; Monstein HJ; Ding XQ; Sundler F; Håkanson R
    Scand J Gastroenterol; 1996 Jan; 31(1):31-7. PubMed ID: 8927937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
    Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
    Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
    Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological effects of long-term acid suppression in man.
    McCloy RF; Arnold R; Bardhan KD; Cattan D; Klinkenberg-Knol E; Maton PN; Riddell RH; Sipponen P; Walan A
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):96S-120S. PubMed ID: 7859587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
    Bardram L; Thomsen P; Stadil F
    Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
    Richards ML; Gauger P; Thompson NW; Giordano TJ
    World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.